Construction and Biocompatibility Evaluation of Fibroin/Sericin-Based Scaffolds

ACS Biomater Sci Eng. 2022 Apr 11;8(4):1494-1505. doi: 10.1021/acsbiomaterials.1c01426. Epub 2022 Mar 1.

Abstract

Because tissue responses to implants determine the success or failure of tissue engineering products, fibroin/sericin-based scaffolds including bionic silk scaffolds, native silk fibers, fibroin fibers, and regenerated fibroin have been fabricated, and their biocompatibility was investigated. Fibroin/sericin-based scaffolds were characterized by scanning electron microscopy (SEM) and X-ray diffraction (XRD). Bionic silk scaffolds were beneficial to silk fiber formation through self-assembly. Histological and immunofluorescent staining analysis demonstrated that bionic silk scaffolds did not show significant inflammatory responses. Immunization analysis showed that soluble fibroin and sericin did not show obvious immunogenicity. This work supplied an effective approach to design fibroin/sericin-based scaffolds for tissue engineering and drug delivery.

Keywords: bionic silk; fibroin; immunization; implantation; inflammatory; sericin.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Fibroins* / pharmacology
  • Sericins* / pharmacology
  • Silk
  • Tissue Engineering
  • Tissue Scaffolds

Substances

  • Sericins
  • Silk
  • Fibroins